ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00769704
Brief Title: Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma

First Submitted : October 7, 2008
First Submitted that Met QC Criteria : October 8, 2008
First Posted : October 9, 2008 (Estimate)

Results First Submitted : September 22, 2015
Results First Submitted that Met QC Criteria : November 12, 2015
Results First Posted : December 17, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : June 14, 2016
Last Update Posted : July 13, 2016 (Estimate)